Bioextrax AB (publ) (STO:BIOEX)
Sweden · Delayed Price · Currency is SEK 2.340
-0.040 (-1.68%)
Sep 3, 2026, 3:46 PM CET
Bioextrax AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 0.6 | 0.76 | 0.52 | 2.06 | 0.4 | 0.28 |
Other Revenue | 0.42 | 0.48 | 0.5 | 0.95 | 1.8 | 0.75 |
| 1.02 | 1.24 | 1.01 | 3.01 | 2.2 | 1.03 | |
Revenue Growth | -19.69% | 22.55% | -66.38% | 36.81% | 113.61% | 363.98% |
Cost of Revenue | 1.06 | 1.26 | 1.43 | 1.34 | 1.35 | 1.03 |
Gross Profit | -0.03 | -0.02 | -0.42 | 1.67 | 0.85 | -0 |
Selling, General & Admin | 17.64 | 16.74 | 16.04 | 22.37 | 19.19 | 10.18 |
Other Operating Expenses | -0.05 | -0.05 | -0.08 | 0.04 | -0.15 | -0 |
Operating Expenses | 18.65 | 17.82 | 17.12 | 23.27 | 19.52 | 10.53 |
Operating Income | -18.68 | -17.84 | -17.54 | -21.6 | -18.67 | -10.53 |
Interest Expense | -0 | -0 | -0 | - | - | -0 |
Interest & Investment Income | 0.11 | 0.14 | 0.2 | 0.09 | - | - |
Other Non Operating Income (Expenses) | -0 | - | - | - | - | - |
Pretax Income | -18.57 | -17.71 | -17.34 | -21.51 | -18.67 | -10.53 |
Net Income | -18.57 | -17.71 | -17.34 | -21.51 | -18.67 | -10.53 |
Net Income to Common | -18.57 | -17.71 | -17.34 | -21.51 | -18.67 | -10.53 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 43 | 40 | 33 | 27 | 17 | 13 |
Shares Outstanding (Diluted) | 43 | 40 | 33 | 27 | 17 | 13 |
Shares Change | 13.87% | 18.85% | 25.69% | 56.94% | 26.08% | 13.76% |
EPS (Basic) | -0.43 | -0.45 | -0.52 | -0.81 | -1.10 | -0.79 |
EPS (Diluted) | -0.43 | -0.45 | -0.52 | -0.81 | -1.10 | -0.79 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -15.98 | -26.2 | -18.99 | -24.41 | -24.38 | -9.45 |
Free Cash Flow Per Share | -0.37 | -0.66 | -0.57 | -0.92 | -1.44 | -0.70 |
Gross Margin | -3.32% | -1.53% | -41.44% | 55.50% | 38.81% | -0.39% |
Operating Margin | -1824.32% | -1439.79% | -1734.82% | -718.29% | -849.27% | -1023.23% |
Profit Margin | -1813.48% | -1428.97% | -1714.94% | -715.23% | -849.27% | -1023.52% |
Free Cash Flow Margin | -1560.74% | -2114.45% | -1878.63% | -811.77% | -1109.19% | -918.56% |
EBITDA | -17.63 | -16.71 | -16.38 | -20.74 | -18.19 | -10.18 |
D&A For EBITDA | 1.05 | 1.13 | 1.16 | 0.86 | 0.48 | 0.35 |
EBIT | -18.68 | -17.84 | -17.54 | -21.6 | -18.67 | -10.53 |
Revenue as Reported | 1.09 | 1.31 | 1.01 | 3.01 | 2.23 | 1.03 |